Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 1,200 shares, an increase of 200.0% from the June 30th total of 400 shares. Based on an average daily volume of 3,700 shares, the short-interest ratio is presently 0.3 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Down 1.3 %

Shares of NASDAQ:HROWM traded down $0.33 on Friday, reaching $25.72. 46,141 shares of the company traded hands, compared to its average volume of 4,171. The business’s 50-day simple moving average is $26.47 and its 200 day simple moving average is $26.21. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52 week low of $22.71 and a 52 week high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Monday, July 15th will be paid a dividend of $0.7422 per share. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.54%. The ex-dividend date is Monday, July 15th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.